Osteonic Co. Ltd - Asset Resilience Ratio
Osteonic Co. Ltd (226400) has an Asset Resilience Ratio of 3.96% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Osteonic Co. Ltd's Asset Resilience Ratio has changed over time. Check Osteonic Co. Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Osteonic Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Osteonic Co. Ltd (226400) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.81 Billion | 3.96% |
| Total Liquid Assets | ₩3.81 Billion | 3.96% |
Asset Resilience Insights
- Limited Liquidity: Osteonic Co. Ltd maintains only 3.96% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Osteonic Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Osteonic Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Osteonic Co. Ltd (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Osteonic Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 22.95% | ₩20.63 Billion ≈ $13.98 Million |
₩89.92 Billion ≈ $60.94 Million |
+2.45pp |
| 2023-12-31 | 20.49% | ₩14.70 Billion ≈ $9.96 Million |
₩71.74 Billion ≈ $48.62 Million |
-7.04pp |
| 2022-12-31 | 27.54% | ₩16.94 Billion ≈ $11.48 Million |
₩61.53 Billion ≈ $41.69 Million |
-6.17pp |
| 2021-12-31 | 33.71% | ₩21.63 Billion ≈ $14.66 Million |
₩64.17 Billion ≈ $43.49 Million |
-3.92pp |
| 2020-12-31 | 37.63% | ₩23.83 Billion ≈ $16.15 Million |
₩63.33 Billion ≈ $42.92 Million |
+13.53pp |
| 2019-12-31 | 24.09% | ₩12.61 Billion ≈ $8.54 Million |
₩52.32 Billion ≈ $35.45 Million |
-10.93pp |
| 2018-12-31 | 35.02% | ₩15.41 Billion ≈ $10.44 Million |
₩44.00 Billion ≈ $29.82 Million |
+19.66pp |
| 2017-12-31 | 15.36% | ₩4.56 Billion ≈ $3.09 Million |
₩29.66 Billion ≈ $20.10 Million |
+1.85pp |
| 2016-12-31 | 13.51% | ₩2.91 Billion ≈ $1.98 Million |
₩21.57 Billion ≈ $14.62 Million |
-4.74pp |
| 2015-12-31 | 18.26% | ₩2.00 Billion ≈ $1.36 Million |
₩10.95 Billion ≈ $7.42 Million |
-- |
About Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more